Pharmacy

Your Article Summary

See Latest Articles

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks' gestational age in Canada
Current Medical Research and Opinion, 06/23/09

Paes B et al. - The RST is a practical, easy-to-use instrument to guide judicious RSV prophylaxis for moderate–high-risk, 33–35-week GA infants. It is cost-effective, reducing hospitalization in infants who are most 'at-risk', while avoiding prophylaxis in a large segment of this GA cohort who are considered low risk for RSV infection.

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate
Expert Opinion in Pharmacotherapy, 12/01/09

Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09

 See all of Antimicrobials

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Vitiligo therapy
Expert Opinion in Pharmacotherapy, 12/01/09

A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients
Bone , 12/01/09

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09

 See all of Other Drugs